BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 2732472)

  • 1. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow.
    Wiltrout RH; Pilaro AM; Gruys ME; Talmadge JE; Longo DL; Ortaldo JR; Reynolds CW
    J Immunol; 1989 Jul; 143(1):372-8. PubMed ID: 2732472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
    Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
    J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
    Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
    J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity.
    Santoni A; Piccoli M; Ortaldo JR; Mason L; Wiltrout RH; Herberman RB
    J Immunol; 1985 Apr; 134(4):2799-810. PubMed ID: 2579157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
    J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2.
    Talmadge JE; Herberman RB; Chirigos MA; Maluish AE; Schneider MA; Adams JS; Philips H; Thurman GB; Varesio L; Long C
    J Immunol; 1985 Oct; 135(4):2483-91. PubMed ID: 2411797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy.
    Shaw SG; Maung AA; Steptoe RJ; Thomson AW; Vujanovic NL
    J Immunol; 1998 Sep; 161(6):2817-24. PubMed ID: 9743341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication.
    Natuk RJ; Welsh RM
    J Immunol; 1987 Feb; 138(3):877-83. PubMed ID: 3027167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic and morphologic profile of endogenous and pyrimidinone-activated murine NK cells.
    Lotzová E; Savary CA; Lowlachi M; Murasko DM
    J Immunol; 1986 Jan; 136(2):732-40. PubMed ID: 2416824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine: I. Activation of natural killer cells in mice.
    Sharma BS; Mhaskar S; Balazs L; Siaw M
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):1-19. PubMed ID: 1597650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator.
    Kalland T; Alm G; Stålhandshe T
    J Immunol; 1985 Jun; 134(6):3956-61. PubMed ID: 2580900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Ly-6E.1-monoclonal-antibody-mediated augmentation of interleukin-2-dependent generation of natural killer cell activity from mouse bone marrow cells.
    Lu L; Herberman RB; DeLeo AB
    Nat Immun; 1994; 13(6):315-30. PubMed ID: 7894202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of natural killer cell production in bone marrow of mice: no evidence for negative feedback control.
    Bilge A; Pollack SB
    Nat Immun; 1992; 11(3):156-66. PubMed ID: 1392403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of hepatic NK cells by IL-12 is dependent on IFN-gamma and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas.
    Fogler WE; Volker K; Watanabe M; Wigginton JM; Roessler P; Brunda MJ; Ortaldo JR; Wiltrout RH
    J Immunol; 1998 Dec; 161(11):6014-21. PubMed ID: 9834083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous development of cells with large granular lymphocyte (LGL) morphology and natural killer (NK) cell lytic activity after bone marrow (BM) transplantation in mice.
    Silvennoinen O; Hurme M
    Immunology; 1988 Jan; 63(1):105-10. PubMed ID: 3276616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of large granular T lymphocytes in vivo during viral infection.
    Biron CA; Natuk RJ; Welsh RM
    J Immunol; 1986 Mar; 136(6):2280-6. PubMed ID: 3485144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.
    Hornung RL; Back TC; Zaharko DS; Urba WJ; Longo DL; Wiltrout RH
    J Immunol; 1988 Nov; 141(10):3671-9. PubMed ID: 2460546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells.
    Reynolds CW; Timonen T; Herberman RB
    J Immunol; 1981 Jul; 127(1):282-7. PubMed ID: 7240744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.